U.S. Healthtech Stock News

TriSalus Life Sciences (TLSI) opened 2026 with Q1 revenue of US$8.9 million and basic EPS of US$0.03, a sharp contrast to the loss of US$0.39 per share on US$9.2 million of revenue in Q1 2025. Over the last year, the company has seen revenue move from US$29.4 million on a trailing basis in Q4 2024 to US$44.9 million in Q1 2026, while trailing EPS remained at a loss of US$1.31 per share, keeping the spotlight firmly on how efficiently that top line is being converted into earnings. Margins are...

Cadence Design Systems (CDNS) is back on investors’ radar after Aeva licensed its Tensilica Vision DSP IP for 4D LiDAR, coinciding with a recent stock upswing and increasing market interest. See our latest analysis for Cadence Design Systems. The recent Aeva licensing news lands after a strong run in the stock, with a 30-day share price return of 23.02% and a 90-day share price return of 22.97%. The 5-year total shareholder return of 189.85% points to momentum that has been in place for a...

CDW (CDW) is back in focus after its Board of Directors approved an additional US$1b for share repurchases, following recent first quarter results that included year over year growth in sales and net income. See our latest analysis for CDW. Despite the fresh buyback authorization and recent dividend affirmation, momentum in the stock has been weak, with the share price down 24.6% year to date and the 1 year total shareholder return declining 46.1%. This points to fading sentiment even after...

TD SYNNEX (NYSE:SNX) has partnered with Aura Business to distribute identity-centric BYOD security solutions across its reseller and MSP network. The collaboration focuses on securing remote and hybrid work setups while maintaining end user privacy. The Aura Business platform will be offered to TD SYNNEX partners as part of its broader cybersecurity and endpoint protection portfolio. For investors tracking TD SYNNEX at a share price of $231.75, this agreement comes during a period of strong...

Recent performance snapshot for SLB (SLB) SLB (SLB) has drawn attention after a period of solid share price performance, with the stock up about 7% over the past month and roughly 9% over the past 3 months. See our latest analysis for SLB. At a share price of US$55.38, SLB’s recent 7 day gain and 30 day share price return of 6.66% sit alongside a stronger year to date share price return of 37.76%. The 1 year total shareholder return of 58.49% points to momentum that has been building over a...

CoStar Group (CSGP) is back in focus after two developments: the reported collapse in U.S. multifamily construction starts and the company’s upcoming removal from the Nasdaq-100, both carrying different signals for real estate exposure. See our latest analysis for CoStar Group. CoStar Group’s recent news comes against a weak share price backdrop, with the stock at US$31.97 after falling about 14% over the past month and around 51% year to date. The 1 year total shareholder return is down...

IFF (NYSE:IFF) has opened a Vanilla Innovation Center in Madagascar, a key origin for natural vanilla. The facility is intended to focus on origin-based product development, sustainability, and local supply chain support. The center links Madagascar vanilla production with IFF’s broader global vanilla network for food, beverage, and fragrance customers. For investors watching NYSE:IFF, this move sits at the intersection of flavor, fragrance, and consumer demand for traceable, natural...

Evolv Technologies Holdings (EVLV) Q1 2026 earnings snapshot Evolv Technologies Holdings (EVLV) opened 2026 with Q1 revenue of US$46.3 million and a basic EPS loss of US$0.03, as investors weigh those figures against a share price of US$6.02. The company reported quarterly revenue of US$32.0 million in Q1 2025 and US$46.3 million in Q1 2026, while basic EPS moved from a loss of US$0.01 in Q1 2025 to a profit of US$0.06 in Q4 2025 before reverting to a loss this quarter. This keeps the...

Recent Share Performance and Business Scale Masco (MAS) has drawn investor attention after a mixed stretch for the stock, with the price around $67.48 and returns varying between gains over the past month and declines over the past 3 months. The company operates two main segments, Plumbing Products and Decorative Architectural Products, generating revenue of about $7.7b and net income of roughly $837.0m, which gives readers a sense of its current scale. See our latest analysis for...

Revolution Medicines (RVMD) is back in focus after the U.S. Food and Drug Administration issued a “safe to proceed” letter for expanded access to its investigational pancreatic cancer therapy, daraxonrasib, for eligible U.S. patients. See our latest analysis for Revolution Medicines. The FDA’s expanded access decision comes after a busy period for Revolution Medicines, with the stock’s 30-day share price return of 10.01% and 90-day share price return of 54.05% pointing to strong momentum. The...

Enovis (ENOV) is back on investors' radar after reaffirming its 2026 revenue guidance of about US$2.31b to US$2.37b and posting first quarter sales of US$589.15m, along with a smaller net loss. See our latest analysis for Enovis. Despite the reaffirmed 2026 guidance and first quarter update, the share price is around US$25.70, with a 90 day share price return of 17.3% but a 1 year total shareholder return that declined 29.0%. This suggests recent momentum following a tougher period. If you...

Earlier in May 2026, Douglas Dynamics reported first-quarter 2026 sales of US$137.8 million and net income of US$6.38 million, raised its full‑year 2026 net sales guidance to US$750 million–US$795 million, completed a US$15 million buyback program covering 451,523 shares, and obtained stockholder approval to add officer exculpation to its Delaware charter. Management also reaffirmed its focus on acquisitions following the Venco Venturo purchase, signaling an intent to use its...

If you are wondering whether American Express stock still offers value after its long run, this section will help you line up the current price with what the underlying business may be worth. The stock closed at US$309.61, with returns that are down 3.8% over the past week, down 4.4% over the past month, down 16.9% year to date, but still up 4.3% over the past year and more than doubling over both the past 3 and 5 years. Recent headlines around American Express have centered on its position...

Inter & Co, Inc. reported first-quarter 2026 net income of R$394.79 million, up from R$286.59 million a year earlier, with basic and diluted earnings per share from continuing operations rising to R$0.89 from R$0.65. The company also recently adopted the “Rule of 50” as its main framework for balancing growth and return on equity over the next three years, signaling a sharper focus on credit penetration, deposit growth and primary-bank relationships. We’ll now examine how Inter & Co’s shift...

Smart Sand (SND) opened 2026 with Q1 revenue of US$93.1 million and a reported loss per share of US$0.10, as net income excluding extra items came in at a loss of US$3.9 million. Over the past year, the company has seen quarterly revenue move between US$65.6 million and US$93.1 million, while quarterly EPS has ranged from a loss of US$0.62 to a profit of US$0.55, with trailing twelve month EPS at US$0.56. For investors, the shift to positive earnings on a trailing basis, alongside a soft...

UBS recently named Take-Two Interactive Software its top pick in the US interactive gaming sector, citing clearer visibility around key franchise releases such as Grand Theft Auto VI and long-term monetization trends, while the company also confirmed CEO Strauss Zelnick’s participation in a TD Cowen technology, media and telecom conference fireside chat later in May 2026. At the same time, Take-Two is reshaping its portfolio by winding down its Private Division indie label, even as GTA...

Amgen (AMGN) is back in focus after first quarter results showed higher revenue and net income versus a year earlier, along with fresh full year guidance and a new US$300 million US manufacturing investment. See our latest analysis for Amgen. The stock has given investors a 32.3% total shareholder return over the past year, even as the 90 day share price return is down 8.1%. This suggests that earlier momentum has cooled while the latest earnings, guidance and US$300 million manufacturing...

Carrier Global (CARR) is back in focus after reporting very large growth in data center related orders, a 35% jump in global Commercial HVAC orders, and reaffirming full year 2026 sales guidance of about US$22b. See our latest analysis for Carrier Global. Despite a modest 1-day share price move and a 7-day share price return that is down 3.43%, Carrier Global’s year-to-date share price return of 22.51% and 3-year total shareholder return of 59.25% point to momentum that remains largely...

Rezolve AI (RZLV) is back in focus after announcing a global partnership with Tata Consultancy Services, under which TCS will resell Rezolve’s AI commerce platform to enterprise clients worldwide and showcase the technology in its Pace Port centers. See our latest analysis for Rezolve AI. The TCS deal lands after an active few weeks, including Rezolve AI’s April guidance reiteration for 2026 revenue of $360 million and the Revolut listing of its SQD token. Yet the stock still sits at a share...

Moderna (NasdaqGS:MRNA) ranked no. 1 on TIME's 2026 World's Most Impactful Companies list. The company received European approval for mCOMBRIAX, its first combined flu and COVID vaccine. These developments expand Moderna's recognized societal role and add a new approved product beyond COVID-only vaccines. For investors following Moderna, this recognition and new approval come as the company continues to build around its mRNA platform in vaccines and therapeutics. The flu plus COVID product...

D-Wave Quantum (NYSE:QBTS) has acquired Quantum Circuits, adding gate-model capabilities alongside its existing annealing systems. The transaction establishes D-Wave as a dual-platform quantum computing company with access to both annealing and gate-model approaches. Recent commercial activity includes a US$20 million system sale to Florida Atlantic University and a large quantum services agreement with a Fortune 100 company. Quarterly bookings were reported to be roughly 20 times higher,...

Wondering whether Howard Hughes Holdings at around US$64.21 is priced for a rebound or still has more to prove on value? This article focuses squarely on what the current share price might imply. The stock has been fairly flat in the short term, up about 0.1% over the last week and down 0.2% over the last month, while the share price has declined 18.5% year to date and 9.6% over the last year. Those longer term moves sit against a backdrop of ongoing interest in real estate development and...

Astronics (ATRO) opened 2026 with Q1 revenue of US$230.6 million and basic EPS of US$1.38, setting a clear marker for how the year is starting after a busy 2025. The company has seen quarterly revenue move from US$205.9 million and EPS of US$0.27 in Q1 2025 to US$230.6 million and EPS of US$1.38 in Q1 2026, while trailing twelve month revenue sits at US$886.8 million and EPS at US$1.28. This puts the spotlight firmly on how much of this uplift is sticking in margins. See our full analysis for...

Broadwind (BWEN) opened Q1 2026 with revenue of US$34.1 million and a basic EPS loss of US$0.02, compared with revenue of US$36.8 million and a basic EPS loss of US$0.02 in Q1 2025, while trailing twelve month EPS stood at US$0.22 on revenue of US$155.3 million. Over recent quarters the company has seen revenue move from US$33.6 million in Q4 2024 to US$36.8 million in Q1 2025, then to US$39.2 million in Q2 2025, US$44.2 million in Q3 2025, US$37.7 million in Q4 2025, and US$34.1 million in...